- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
FXR Antibody / Bile Acid Receptor Polyclonal Antibody targets farnesoid X receptor (FXR), a ligand-activated transcription factor encoded by the NR1H4 gene. FXR belongs to the nuclear receptor superfamily and functions as an intracellular sensor of bile acid availability. Through its ability to regulate gene transcription in response to endogenous bile acids, FXR coordinates metabolic processes that maintain bile acid balance and influence cholesterol, lipid, and glucose homeostasis.
Bile acids are synthesized from cholesterol and participate in intestinal lipid absorption, but they also act as signaling molecules that regulate metabolic activity. FXR responds to several naturally occurring bile acids, including chenodeoxycholic acid, which is a potent endogenous activator. Ligand binding promotes conformational changes within the receptor that influence interactions with transcriptional coregulators. FXR commonly forms heterodimers with retinoid X receptor (RXR), allowing the complex to recognize specific DNA response elements and regulate the expression of genes involved in bile acid transport and metabolism.
A major function of FXR is coordinating the enterohepatic circulation of bile acids. Activation of intestinal FXR stimulates expression of fibroblast growth factor 19 (FGF19), which participates in endocrine signaling between the intestine and liver. Hepatic FXR also induces small heterodimer partner (SHP), an atypical nuclear receptor that contributes to repression of bile acid synthesis. Together, these regulatory mechanisms limit excessive bile acid production and help protect cells from the potentially damaging effects of elevated intracellular bile acid concentrations.
FXR additionally influences metabolic pathways beyond bile acid regulation. Its transcriptional targets participate in triglyceride metabolism, cholesterol transport, and glucose homeostasis. FXR signaling can also modulate inflammatory responses and epithelial barrier function, linking bile acid sensing to broader aspects of tissue physiology. Dysregulated FXR activity has been investigated in cholestatic disorders, metabolic dysfunction-associated steatotic liver disease, and other conditions involving altered lipid metabolism or bile acid signaling.
Research involving FXR Antibody contributes to understanding how NR1H4 expression relates to transcriptional control of metabolic pathways. The receptor's integration of bile acid sensing, endocrine communication, and inflammatory regulation makes it an important component of the molecular mechanisms governing metabolic homeostasis.
For additional research into farnesoid X receptor signaling, explore our NR1H4 Antibody, which features knockout-validated Western blot analysis and complementary cellular staining data.
Optimal dilution of the FXR Antibody / Bile Acid Receptor Polyclonal Antibody should be determined by the researcher.
Amino acids KSCREKTELTPDQQ were used as the immunogen for this FXR antibody.
Aliquot and store the FXR antibody at -20oC.
Farnesoid X receptor antibody, Bile acid receptor antibody, Nuclear receptor subfamily 1 group H member 4 antibody, NR1H4 antibody, BAR antibody, RIP14 antibody, Retinoid X receptor-interacting protein 14 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.